Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
910
Trial Sponsor
Clinical Trial Start Date
2007
0Primary Completion Date
2010
0Study Completion Date
2010
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Biological0
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderate to Severe Diabetic Neuropathy and Unmeasurable Nerve Conduction Velocity0
Last Updated
November 1, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Single0
Masked Party
Investigator0
Other attributes
Intervention Treatment
Placebo0
SB-5090
Study summary
The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
